首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
RituximabCOVID-19 infection: 2 case reports
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2020年
/ 1833卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-020-87160-5
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:342 / 342
相关论文
共 50 条
[41]
Remdesivir/rituximabCOVID-19 infection and COVID-19 infection rebound: case report
Reactions Weekly,
2022,
1927
(1)
: 461
-
461
[42]
RituximabCOVID-19 pneumonia
Reactions Weekly,
2024,
2017
(1)
: 439
-
439
[43]
RituximabCovid-19 infection following exposure during pregnancy: case report
Reactions Weekly,
2023,
1946
(1)
: 490
-
490
[44]
RituximabCOVID-19 pneumonia and herpes simplex virus infection: case report
Reactions Weekly,
2022,
1889
(1)
: 278
-
278
[45]
Prednisone/rituximabCOVID-19 pneumonia: case report
Reactions Weekly,
2021,
1838
(1)
: 456
-
456
[46]
Bendamustine/rituximabCOVID-19 pneumonia: case report
Reactions Weekly,
2021,
1861
(1)
: 72
-
72
[47]
Bendamustine/obinutuzumab/rituximabCOVID-19 infection and prolonged COVID-19 virus positivity: case report
Reactions Weekly,
2022,
1922
(1)
: 134
-
134
[48]
Prednisolone/rituximabCOVID-19 and SARS-CoV-2 pneumonia: case report
Reactions Weekly,
2021,
1879
(1)
: 318
-
318
[49]
Covid-19-vaccine/rituximabCOVID-19 infection and lack of efficacy caused by drug interactions: case report
Reactions Weekly,
2021,
1879
(1)
: 114
-
114
[50]
Ciclosporin/everolimus/rituximabCOVID-19, Epstein-Barr virus infection and COVID-19 reinfection: case report
Reactions Weekly,
2021,
1885
(1)
: 147
-
147
←
1
2
3
4
5
→